HAL vs LUNG · P/E 9.3, $19.05B cap vs rev $83.8M
Halliburton Company (HAL) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported LUNG revenue for 2024-12-31 was $83.8M. Net income was -$56.4M. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. LUNG currently screens at market cap $111.9M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. LUNG currently screens at market cap $111.9M.
Not investment advice. Open the HAL and LUNG stock pages for the full models.
Not investment advice.